WallStreetZenWallStreetZen

NASDAQ: VERA
Vera Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VERA

Based on 4 analysts offering 12 month price targets for Vera Therapeutics Inc.
Min Forecast
$6.00-13.92%
Avg Forecast
$16.75+140.32%
Max Forecast
$38.00+445.19%

Should I buy or sell VERA stock?

Based on 4 analysts offering ratings for Vera Therapeutics Inc.
Buy
Strong Buy
1 analysts 25%
Buy
1 analysts 25%
Hold
2 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VERA stock forecasts and price targets.

VERA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Jefferies
Bottom 10%
10
HoldDowngrades$6.00-13.92%2023-01-04
Wedbush
Bottom 4%
4
HoldDowngrades$8.00+14.78%2023-01-04
HC Wainwright & Co.
Top 11%
90
BuyMaintains$15.00+115.21%2023-01-04
JP Morgan
Bottom 1%
1
Strong BuyMaintains$38.00+445.19%2022-11-18

1 of 1

Forecast return on equity

Is VERA forecast to generate an efficient return?
Company
N/A
Industry
0.02%
Market
13.26%

Forecast return on assets

Is VERA forecast to generate an efficient return on assets?
Company
N/A
Industry
0.14%

VERA earnings per share forecast

What is VERA's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
-$3.52
Avg 2 year Forecast
-$3.52
Avg 3 year Forecast
-$2.97

VERA revenue forecast

What is VERA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$19.7M
Avg 2 year Forecast
$101.2M
Avg 3 year Forecast
$297.1M

VERA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VERA$6.97$16.75+140.32%Buy
KMPH$5.56$16.67+199.77%Strong Buy
MLEC$5.17N/AN/A
CTXR$1.33$6.67+401.20%Strong Buy
AKBA$1.07$1.63+51.87%Hold
View Top Biotech Stocks

Vera Therapeutics Stock Forecast FAQ

Is Vera Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: VERA) stock is to Buy VERA stock.

Out of 4 analysts, 1 (25%) are recommending VERA as a Strong Buy, 1 (25%) are recommending VERA as a Buy, 2 (50%) are recommending VERA as a Hold, 0 (0%) are recommending VERA as a Sell, and 0 (0%) are recommending VERA as a Strong Sell.

If you're new to stock investing, here's how to buy Vera Therapeutics stock.

What is VERA's earnings growth forecast for 2023-2025?

(NASDAQ: VERA) Vera Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 21.89%.

Vera Therapeutics's earnings in 2023 is -$73,464,000.On average, 5 Wall Street analysts forecast VERA's earnings for 2023 to be -$97,354,893, with the lowest VERA earnings forecast at -$139,947,658, and the highest VERA earnings forecast at -$80,760,309. On average, 4 Wall Street analysts forecast VERA's earnings for 2024 to be -$97,354,893, with the lowest VERA earnings forecast at -$141,607,117, and the highest VERA earnings forecast at -$59,740,502.

In 2025, VERA is forecast to generate -$82,143,191 in earnings, with the lowest earnings forecast at -$116,438,664 and the highest earnings forecast at -$52,272,940.

What is VERA's revenue growth forecast for 2025-2027?

(NASDAQ: VERA) Vera Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.2%.

Vera Therapeutics's revenue in 2023 is $0.On average, 1 Wall Street analysts forecast VERA's revenue for 2025 to be $545,132,084, with the lowest VERA revenue forecast at $545,132,084, and the highest VERA revenue forecast at $545,132,084. On average, 3 Wall Street analysts forecast VERA's revenue for 2026 to be $2,798,676,592, with the lowest VERA revenue forecast at $512,247,150, and the highest VERA revenue forecast at $6,733,805,611.

In 2027, VERA is forecast to generate $8,216,061,511 in revenue, with the lowest revenue forecast at $3,879,011,668 and the highest revenue forecast at $13,823,565,048.

What is VERA's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: VERA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.14%.

What is VERA's Price Target?

According to 4 Wall Street analysts that have issued a 1 year VERA price target, the average VERA price target is $16.75, with the highest VERA stock price forecast at $38.00 and the lowest VERA stock price forecast at $6.00.

On average, Wall Street analysts predict that Vera Therapeutics's share price could reach $16.75 by Jan 4, 2024. The average Vera Therapeutics stock price prediction forecasts a potential upside of 140.32% from the current VERA share price of $6.97.

What is VERA's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: VERA) Vera Therapeutics's current Earnings Per Share (EPS) is -$3.14. On average, analysts forecast that VERA's EPS will be -$3.52 for 2023, with the lowest EPS forecast at -$5.06, and the highest EPS forecast at -$2.92. On average, analysts forecast that VERA's EPS will be -$3.52 for 2024, with the lowest EPS forecast at -$5.12, and the highest EPS forecast at -$2.16. In 2025, VERA's EPS is forecast to hit -$2.97 (min: -$4.21, max: -$1.89).

What is VERA's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: VERA) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.